Immune Checkpoint Inhibitor-Associated Central Adrenal Insufficiency.
作者信息
Mishra Tushar, He Gong, Sreeram Kalyan, Rauf Mohammad, Subahi Ahmed, Hazem Mariam
机构信息
Department of Internal Medicine, Wayne State University/Detroit Medical Center, Detroit, MI.
出版信息
Am J Ther. 2019 Sep/Oct;26(5):e626-e627. doi: 10.1097/MJT.0000000000000832.
PMID:30277909
Abstract
摘要
相似文献
1
Immune Checkpoint Inhibitor-Associated Central Adrenal Insufficiency.免疫检查点抑制剂相关的中枢性肾上腺皮质功能减退
Am J Ther. 2019 Sep/Oct;26(5):e626-e627. doi: 10.1097/MJT.0000000000000832.
2
Case of hypophysitis caused by nivolumab.纳武单抗引起的垂体炎病例。
J Dermatol. 2017 Jan;44(1):109-110. doi: 10.1111/1346-8138.13437. Epub 2016 May 14.
3
Hyponatremia in a Patient With Cancer.癌症患者的低钠血症
Am J Kidney Dis. 2020 Jan;75(1):A15-A18. doi: 10.1053/j.ajkd.2019.09.005.
4
Nivolumab-induced hypophysitis causing secondary adrenal insufficiency after transient ACTH elevation.尼伏鲁单抗引起的垂体炎，在 ACTH 短暂升高后导致继发性肾上腺功能不全。
Endocr J. 2019 Oct 28;66(10):937-941. doi: 10.1507/endocrj.EJ19-0076. Epub 2019 Jun 19.
5
Nivolumab-induced Hypophysitis, Secondary Adrenal Insufficiency and Destructive Thyroiditis in a Patient with Lung Adenocarcinoma.一名肺腺癌患者出现纳武单抗诱导的垂体炎、继发性肾上腺功能不全和破坏性甲状腺炎
Intern Med. 2019 Mar 1;58(5):693-697. doi: 10.2169/internalmedicine.1268-18. Epub 2018 Nov 19.
6
Progression of Hypopituitarism and Hypothyroidism after Treatment with Pembrolizumab in a Patient with Adrenal Metastasis from Non-small-cell Lung Cancer.帕博利珠单抗治疗非小细胞肺癌肾上腺转移患者后垂体功能减退和甲状腺功能减退的进展
Intern Med. 2019 Dec 15;58(24):3557-3562. doi: 10.2169/internalmedicine.3008-19. Epub 2019 Aug 28.
7
HTLV-1 seropositive patients with lung cancer treated with PD-1 inhibitors.接受PD-1抑制剂治疗的HTLV-1血清阳性肺癌患者。
Cancer Sci. 2020 Sep;111(9):3395-3396. doi: 10.1111/cas.14536. Epub 2020 Jul 18.
8
Immune checkpoint inhibitor-associated hypophysitis-World Health Organisation VigiBase report analysis.免疫检查点抑制剂相关垂体炎——世界卫生组织药物不良反应数据库报告分析
Eur J Cancer. 2019 May;113:10-13. doi: 10.1016/j.ejca.2019.03.002. Epub 2019 Apr 4.
9
Corticotropic insufficiency in a monocentric prospective cohort of patients with lung cancer treated with nivolumab: Prevalence and etiology.在一项接受nivolumab 治疗的肺癌患者的单中心前瞻性队列研究中皮质激素功能不全的发生率和病因。
Ann Endocrinol (Paris). 2021 Feb;82(1):8-14. doi: 10.1016/j.ando.2020.11.010. Epub 2020 Dec 5.
10
Diabetic ketoacidosis following immunotherapy for lung cancer.肺癌免疫治疗后发生的糖尿病酮症酸中毒
Tidsskr Nor Laegeforen. 2019 Feb 25;139(4). doi: 10.4045/tidsskr.18.0597. Print 2019 Feb 26.
Zotero 插件